De novo pyrimidine synthesis controls lupus-prone germinal center B cell and plasma cell fates 2304696

Abstract Introduction The role of pyrimidine metabolites in SLE-prone germinal center (GC) and plasma cell (PC) responses is unknown. Methods A combination of steady-state metabolomics analysis and isotopic 15N-glutamine tracing were used to examine metabolic flux through de novo pyrimidine synthesis pathway in SLE-prone B cells. To examine role of the de novo pyrimidine synthesis pathway in the SLE autoimmune phenotype, global inhibition in SLE-prone mice was tested first, then UMPS conditional knockout SLE-prone mice were generated and phenotyped. Steady-state metabolomics, mitochondrial stress test, and metabolic flow cytometry were employed to elucidate a role for de novo pyrimidine synthesis in regulating metabolic pathways. Results Metabolomics and 15N-amide glutamine tracing reveal enhanced flux through pyrimidine synthesis in SLE-prone B cells. Global inhibition of de novo pyrimidine synthesis in SLE-prone mice dampened GC, PC and autoantibody responses, and kidney immune complex (IC) deposition. This inhibition did not overtly affect foreign antigen-driven GC, PC, and antibody responses. Newly generated UMPS conditional knockout SLE-prone mice revealed a B cell-intrinsic requirement of de novo pyrimidine synthesis in spontaneous GC, PC and autoantibody responses, and kidney IC deposition. Metabolomics, mitochondrial stress-test and metabolic flow cytometry helped delineate a crucial role for pyrimidine synthesis in B cell metabolic reprogramming that promotes autoimmunity. Mechanistically, mTORC1 and S6K1 downstream of TLR7 and CD40 signaling in B cells activate CAD, which catalyzes the first three steps of pyrimidine synthesis and upregulates de novo pyrimidine synthesis. Conclusion We identify a previously unknown B cell-intrinsic requirement of the pyrimidine pathway in autoimmune GC and PC responses, development of autoreactive B cells, and autoantibodies in SLE. Funding Source RO1 AI162971 RO1 AI194568 Finkelstein Memorial Student Research Award Topic Categories Basic Autoimmunity (BA)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2026-07-28
DOI
https://doi.org/10.1093/jimmun/vkag141.1281
Primary Topic
Biochemical and Molecular Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

De novo pyrimidine synthesis controls lupus-prone germinal center B cell and plasma cell fates 2304696

Wujuan Zhang, Anju Maharjan, Sathi Babu Chodisetti, Júlia Wéber et al.
The Journal of Immunology
Biochemical and Molecular Research
article

De novo pyrimidine synthesis controls lupus-prone germinal center B cell and plasma cell fates 2304696

Wujuan Zhang, Anju Maharjan, Sathi Babu Chodisetti, Júlia Wéber, Aaron Goldman, Keomonyroth Nuon, Sophia Crocker, Tien Bui, Ziaur Rahman, Adam Fike, Kristen Bricker
article en

Abstract

Abstract Introduction The role of pyrimidine metabolites in SLE-prone germinal center (GC) and plasma cell (PC) responses is unknown. Methods A combination of steady-state metabolomics analysis and isotopic 15N-glutamine tracing were used to examine metabolic flux through de novo pyrimidine synthesis pathway in SLE-prone B cells. To examine role of the de novo pyrimidine synthesis pathway in the SLE autoimmune phenotype, global inhibition in SLE-prone mice was tested first, then UMPS conditional knockout SLE-prone mice were generated and phenotyped. Steady-state metabolomics, mitochondrial stress test, and metabolic flow cytometry were employed to elucidate a role for de novo pyrimidine synthesis in regulating metabolic pathways. Results Metabolomics and 15N-amide glutamine tracing reveal enhanced flux through pyrimidine synthesis in SLE-prone B cells. Global inhibition of de novo pyrimidine synthesis in SLE-prone mice dampened GC, PC and autoantibody responses, and kidney immune complex (IC) deposition. This inhibition did not overtly affect foreign antigen-driven GC, PC, and antibody responses. Newly generated UMPS conditional knockout SLE-prone mice revealed a B cell-intrinsic requirement of de novo pyrimidine synthesis in spontaneous GC, PC and autoantibody responses, and kidney IC deposition. Metabolomics, mitochondrial stress-test and metabolic flow cytometry helped delineate a crucial role for pyrimidine synthesis in B cell metabolic reprogramming that promotes autoimmunity. Mechanistically, mTORC1 and S6K1 downstream of TLR7 and CD40 signaling in B cells activate CAD, which catalyzes the first three steps of pyrimidine synthesis and upregulates de novo pyrimidine synthesis. Conclusion We identify a previously unknown B cell-intrinsic requirement of the pyrimidine pathway in autoimmune GC and PC responses, development of autoreactive B cells, and autoantibodies in SLE. Funding Source RO1 AI162971 RO1 AI194568 Finkelstein Memorial Student Research Award Topic Categories Basic Autoimmunity (BA)

The Journal of ImmunologyVol. 215(Supplement_1)
The Wistar Institute (US), Pennsylvania State University (US), Thomas Jefferson University (US)
Openalex Percentile: Top 14%
Biochemical and Molecular Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.